Science
Inflammation is not the enemy. A stuck alarm is.
When a splinter goes into a finger, the skin around it reddens, swells and hurts. That is inflammation doing its job.
Cells of the innate immune system detect that something is wrong, release signalling molecules, and summon help. Within a few days the splinter is dealt with, the signal stops, and the finger returns to normal.
Alarm panel
A fire alarm with three parts.
The system that raises that alarm is a protein machine called an inflammasome. Think of it as a fire alarm panel with three parts. A sensor notices that something is wrong. An adaptor passes the message on. An effector sounds the alarm by converting a dormant inflammatory signal into its active form and releasing it.
In some people the panel never resets.
A small number of people are born with a change in the sensor gene that leaves it too easily triggered. The alarm fires without a fire. The resulting conditions are grouped under the name cryopyrin-associated periodic syndromes, and they include familial cold autoinflammatory syndrome and Muckle-Wells syndrome. They bring recurring fever, rashes that look like hives, joint pain, and in the severest forms, damage to hearing and to the kidneys.
The same alarm panel, firing in the wrong place or for too long, also appears in gout, where it responds to crystals in a joint, and in the cytokine storm that can follow a severe infection.
Why silencing beats blocking.
The approved medicines for these conditions all work downstream. They intercept the inflammatory signal after the cell has made and released it. It is an effective strategy and it has changed lives. It is also a strategy that has to be repeated for life, because the panel keeps producing the signal and the drug keeps catching it.
A short interfering RNA works differently. Rather than catching the product, it instructs the cell to stop making the parts. Deliver a sequence matched to the message and the cell degrades that message before a protein is ever built.
The sensor is not blocked. It is not there.
Upstream
Three routes, and what each leaves behind.
Data
What we measured, and how.
In mice, a single intravenous dose of siRNA in our lipopolymer was measured directly in tissue one day later, with five animals per group. In human cells, immune cells separated from the blood of fifteen healthy volunteers were treated outside the body, and the release of the inflammatory signal was measured.